Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

28/14/28	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
04/14/04	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
01/14/01	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/13/20	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
01/13/01	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)
16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	01/01/2021
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	+1.81%	+1.60%	+13.40%	+84.45%	4.72TCr
OTSUKA HOLDINGS CO., LTD.	-2.54%	+3.72%	+65.71%	+113.61%	3.79TCr
CIPLA LIMITED	+0.15%	+0.28%	-3.35%	+45.56%	1.24TCr
ZYDUS LIFESCIENCES LIMITED	+3.71%	+1.72%	+14.13%	+97.20%	1.15TCr
KRKA, D. D.	+2.04%	-1.72%	+32.73%	+121.98%	892.89Cr
GEDEON RICHTER	+0.25%	-0.98%	+18.79%	+44.96%	713.92Cr
ONO PHARMACEUTICAL CO., LTD.	+0.71%	+1.75%	+53.59%	-7.09%	701.52Cr
GLENMARK PHARMACEUTICALS LIMITED	+0.68%	+1.12%	+23.97%	+235.28%	650.96Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+6.55%	+16.24%	-23.92%	+16.83%	598.06Cr
Average	+1.44%	+3.75%	+21.67%	+83.64%	1.61TCr
Weighted average by Cap.	+0.68%	+3.13%	+28.10%	+89.72%

Employees

Sector